Company · CIK 0001679082 · SIC 2834 — Pharmaceutical Preparations
Myovant Sciences Ltd. · MYOV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2019 SForm 4 → | Feb 20, 4:25 pm EST | Ferreira Juan Camilo ArjonaChief Medical Officer | 260 | $21.15 | $5,499 | 9,740 | −2.60% | plan? |
| Dec 17, 2018 AForm 4 → | Dec 18, 5:15 pm EST | Kim SablichChief Commercial Officer | 29,700 | — | — | 29,700 | — | plan? |
| Apr 2, 2018 PForm 4 → | Apr 5, 6:02 am EDT | VIKING GLOBAL INVESTORS LP +610% Owner | 1,110,015 | $20.27 | $22,500,004 | 38,341,357 | +2.98% | plan? late |
| Apr 2, 2018 PForm 4 → | Apr 4, 9:58 pm EDT | VIKING GLOBAL PERFORMANCE LLC +510% Owner | 1,110,015 | $20.27 | $22,500,004 | 38,341,357 | +2.98% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 4, 7:18 pm EDT | Dexxon Holdings Ltd. +210% Owner | 1,110,015 | $20.27 | $22,500,004 | 38,341,357 | +2.98% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 4, 5:00 pm EDT | Andrew Lo10% Owner | 1,110,015 | $20.27 | $22,500,004 | 38,341,357 | +2.98% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 4, 4:59 pm EDT | SVF Investments (UK) Ltd +310% Owner | 1,110,015 | $20.27 | $22,500,004 | 38,341,357 | +2.98% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 4, 4:52 pm EDT | Roivant Sciences Ltd.10% Owner | 1,110,015 | $20.27 | $22,500,004 | 38,341,357 | +2.98% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 4, 4:51 pm EDT | Patrick Machado10% Owner | 1,110,015 | $20.27 | $22,500,004 | 38,341,357 | +2.98% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 4, 4:29 pm EDT | QVT Associates GP LLC +1Director, 10% Owner | 1,110,015 | $20.27 | $22,500,004 | 38,341,357 | +2.98% | plan? |
| Mar 19, 2018 PForm 4 → | Mar 21, 9:42 pm EDT | Takeda Pharmaceuticals International AG +410% Owner | 7,420,625 | $18.67 | $138,543,069 | 7,420,625 | — | plan? |
| Mar 19, 2018 SForm 4 → | Mar 21, 9:42 pm EDT | Takeda Pharmaceuticals International AG +410% Owner | 7,420,625 | $18.67 | $138,543,069 | 0 | −100% | plan? |
| Nov 17, 2017 PForm 4 → | Jun 15, 2018, 5:20 pm EDT | Mark AltmeyerDirector | 3,500 | $13.38 | $46,830 | 3,500 | — | plan? late |
| Aug 15, 2017 AForm 4 → | Aug 17, 7:19 pm EDT | Ferreira Juan Camilo ArjonaChief Medical Officer | 10,000 | — | — | 10,000 | — | plan? |
| May 31, 2017 AForm 4 → | Jun 2, 6:35 pm EDT | Lynn SeelyPrincipal Executive Officer, Director | 564,111 | — | — | 1,692,333 | — | plan? |
| Apr 17, 2017 MForm 4 → | Apr 19, 4:12 pm EDT | Takeda Pharmaceuticals International AG10% Owner | 4,432 | — | — | 7,420,625 | — | plan? |
| Feb 15, 2017 MForm 4 → | Mar 24, 6:00 pm EDT | Takeda Pharmaceuticals International AG10% Owner | 19,936 | — | — | 7,416,193 | — | plan? late |
| Dec 15, 2016 MForm 4 → | Mar 13, 2017, 4:34 pm EDT | Takeda Pharmaceuticals International AG10% Owner | 27,868 | — | — | 7,396,257 | — | plan? late |
| Nov 1, 2016 MForm 4 → | Nov 3, 4:49 pm EDT | Takeda Pharmaceuticals International AG10% Owner | 1,977,269 | — | — | 7,368,389 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2018 AForm 4 → | Dec 18, 5:15 pm EST | Kim SablichChief Commercial Officer | 133,500 | — | — | 133,500 | — | |
| Nov 6, 2018 AForm 4 → | Nov 8, 5:22 pm EST | Frank TortiDirector | 45,000 | — | — | 45,000 | — | |
| Sep 20, 2018 AForm 4 → | Sep 24, 4:42 pm EDT | Myrtle S PotterDirector | 45,000 | — | — | 45,000 | — | |
| Aug 31, 2018 AForm 4 → | Sep 4, 4:48 pm EDT | Kathleen SebeliusDirector | 22,500 | — | — | 22,500 | — | |
| Aug 31, 2018 AForm 4 → | Sep 4, 4:47 pm EDT | Terrie CurranDirector | 22,500 | — | — | 22,500 | — | |
| Aug 31, 2018 AForm 4 → | Sep 4, 4:44 pm EDT | Mark AltmeyerDirector | 22,500 | — | — | 22,500 | — | |
| Jul 23, 2018 AForm 4 → | Jul 24, 7:10 pm EDT | Mark GuinanDirector | 45,000 | — | — | 45,000 | — | |
| Apr 16, 2018 AForm 4 → | Apr 18, 6:42 pm EDT | Matthew LangGeneral Counsel & Corp. Secy. | 87,050 | — | — | 87,050 | — | |
| Apr 16, 2018 AForm 4 → | Apr 18, 6:41 pm EDT | Lynn SeelyPrincipal Executive Officer, Director | 248,450 | — | — | 248,450 | — | |
| Apr 16, 2018 AForm 4 → | Apr 18, 6:40 pm EDT | Frank KarbePrincipal Fin'l & Accounting | 114,690 | — | — | 114,690 | — | |
| Apr 16, 2018 AForm 4 → | Apr 18, 6:39 pm EDT | Ferreira Juan Camilo ArjonaChief Medical Officer | 87,050 | — | — | 87,050 | — | |
| Aug 18, 2017 AForm 4 → | Oct 20, 4:47 pm EDT | Kathleen SebeliusDirector | 22,500 | — | — | 22,500 | — | late |
| Aug 18, 2017 AForm 4 → | Oct 20, 4:46 pm EDT | Wayne S DeVeydtDirector | 22,500 | — | — | 22,500 | — | late |
| Aug 18, 2017 AForm 4 → | Oct 20, 4:45 pm EDT | Terrie CurranDirector | 22,500 | — | — | 22,500 | — | late |
| Aug 18, 2017 AForm 4 → | Oct 20, 4:45 pm EDT | Mark AltmeyerDirector | 22,500 | — | — | 22,500 | — | late |
| Aug 15, 2017 AForm 4 → | Aug 17, 7:19 pm EDT | Ferreira Juan Camilo ArjonaChief Medical Officer | 260,000 | — | — | 260,000 | — | |
| Jul 17, 2017 AForm 4 → | Jul 18, 6:33 am EDT | Matthew LangGeneral Counsel & Corp. Secy. | 310,000 | — | — | 310,000 | — | |
| May 15, 2017 AForm 4 → | May 17, 5:18 pm EDT | Mark AltmeyerDirector | 11,154 | — | — | 11,154 | — | |
| May 15, 2017 AForm 4 → | May 17, 5:17 pm EDT | Kathleen SebeliusDirector | 11,154 | — | — | 11,154 | — | |
| May 15, 2017 AForm 4 → | May 17, 5:16 pm EDT | Wayne S DeVeydtDirector | 11,154 | — | — | 11,154 | — | |
| May 15, 2017 AForm 4 → | May 17, 5:12 pm EDT | Terrie CurranDirector | 11,154 | — | — | 11,154 | — | |
| May 15, 2017 AForm 4 → | May 17, 5:11 pm EDT | Lynn SeelyPrincipal Executive Officer, Director | 400,000 | — | — | 400,000 | — | |
| May 15, 2017 AForm 4 → | May 17, 5:09 pm EDT | Frank KarbePrincipal Fin'l & Accounting | 200,000 | — | — | 200,000 | — | |
| Apr 17, 2017 MForm 4 → | Apr 19, 4:12 pm EDT | Takeda Pharmaceuticals International AG10% Owner | 4,432 | — | — | 0 | — | |
| Feb 15, 2017 MForm 4 → | Mar 24, 6:00 pm EDT | Takeda Pharmaceuticals International AG10% Owner | 19,936 | — | — | 0 | — | late |
| Dec 15, 2016 MForm 4 → | Mar 13, 2017, 4:34 pm EDT | Takeda Pharmaceuticals International AG10% Owner | 27,868 | — | — | 0 | — | late |
| Nov 15, 2016 AForm 4 → | Nov 17, 4:30 pm EST | Terrie CurranDirector | 33,846 | — | — | 33,846 | — | |
| Nov 1, 2016 MForm 4 → | Nov 3, 4:49 pm EDT | Takeda Pharmaceuticals International AG10% Owner | 1,977,269 | — | — | 0 | — |